WallStreetZenWallStreetZen

NASDAQ: SMTI
Sanara Medtech Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for SMTI

Based on 3 analysts offering 12 month price targets for Sanara Medtech Inc

Min Forecast
$32.00-8.18%
Avg Forecast
$34.00-2.44%
Max Forecast
$35.00+0.43%

Should I buy or sell SMTI stock?

Based on 3 analysts offering ratings for Sanara Medtech Inc.

Strong Buy
Strong Buy
2 analysts 66.67%
Buy
0 analysts 0%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SMTI stock forecasts and price targets.

SMTI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-07-30
lockedlocked$00.00+00.00%2026-06-17
lockedlocked$00.00+00.00%2026-04-15

1 of 1

Forecast return on equity

Is SMTI forecast to generate an efficient return?

Company
N/A
Industry
23.76%
Market
168.15%

Forecast return on assets

Is SMTI forecast to generate an efficient return on assets?

Company
N/A
Industry
17.3%

SMTI earnings per share forecast

What is SMTI's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$0.19
Avg 2 year Forecast
$0.60
Avg 3 year Forecast
$0.91

SMTI revenue forecast

What is SMTI's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$119.3M+8.65%
Avg 2 year Forecast
$134.8M+22.79%
Avg 3 year Forecast
$151.7M+38.11%
SMTI's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SMTI revenue growth forecast

How is SMTI forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
11.28%
Industry
8.55%
Market
14.51%
SMTI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SMTI's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SMTI vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
SMTI$34.85$34.00-2.44%Strong Buy
EMBC$5.65$4.00-29.20%Hold
OSUR$3.97N/AN/A
INFU$13.16$20.00+51.98%Strong Buy
UTMD$74.13N/AN/A
View Top Medical Stocks

Sanara Medtech Stock Forecast FAQ

Is Sanara Medtech Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: SMTI) stock is to Strong Buy SMTI stock.

Out of 3 analysts, 2 (66.67%) are recommending SMTI as a Strong Buy, 0 (0%) are recommending SMTI as a Buy, 1 (33.33%) are recommending SMTI as a Hold, 0 (0%) are recommending SMTI as a Sell, and 0 (0%) are recommending SMTI as a Strong Sell.

If you're new to stock investing, here's how to buy Sanara Medtech stock.

What is SMTI's earnings growth forecast for 2026-2028?

(NASDAQ: SMTI) Sanara Medtech's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 28.93%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.53%.

Sanara Medtech's earnings in 2026 is -$32,014,974.On average, 5 Wall Street analysts forecast SMTI's earnings for 2026 to be $1,780,641, with the lowest SMTI earnings forecast at $1,440,684, and the highest SMTI earnings forecast at $2,025,962. On average, 5 Wall Street analysts forecast SMTI's earnings for 2027 to be $5,529,359, with the lowest SMTI earnings forecast at $4,952,351, and the highest SMTI earnings forecast at $6,077,885.

In 2028, SMTI is forecast to generate $8,340,898 in earnings, with the lowest earnings forecast at $8,013,804 and the highest earnings forecast at $8,586,219.

What is SMTI's revenue growth forecast for 2026-2028?

(NASDAQ: SMTI) Sanara Medtech's forecast annual revenue growth rate of 11.28% is forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.55%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.51%.

Sanara Medtech's revenue in 2026 is $109,814,925.On average, 5 Wall Street analysts forecast SMTI's revenue for 2026 to be $1,096,224,456, with the lowest SMTI revenue forecast at $1,038,156,075, and the highest SMTI revenue forecast at $1,144,185,999. On average, 5 Wall Street analysts forecast SMTI's revenue for 2027 to be $1,238,914,639, with the lowest SMTI revenue forecast at $1,181,397,540, and the highest SMTI revenue forecast at $1,286,968,062.

In 2028, SMTI is forecast to generate $1,393,549,268 in revenue, with the lowest revenue forecast at $1,338,972,341 and the highest revenue forecast at $1,434,619,785.

What is SMTI's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: SMTI) forecast ROA is N/A, which is lower than the forecast US Medical Instruments & Supplies industry average of 17.3%.

What is SMTI's Price Target?

According to 3 Wall Street analysts that have issued a 1 year SMTI price target, the average SMTI price target is $34.00, with the highest SMTI stock price forecast at $35.00 and the lowest SMTI stock price forecast at $32.00.

On average, Wall Street analysts predict that Sanara Medtech's share price could fall to $34.00 by Jul 30, 2027. The average Sanara Medtech stock price prediction forecasts a potential downside of 2.44% from the current SMTI share price of $34.85.

What is SMTI's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: SMTI) Sanara Medtech's current Earnings Per Share (EPS) is -$3.70. On average, analysts forecast that SMTI's EPS will be $0.19 for 2026, with the lowest EPS forecast at $0.16, and the highest EPS forecast at $0.22. On average, analysts forecast that SMTI's EPS will be $0.60 for 2027, with the lowest EPS forecast at $0.54, and the highest EPS forecast at $0.66. In 2028, SMTI's EPS is forecast to hit $0.91 (min: $0.87, max: $0.93).

What is SMTI's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: SMTI) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.